Use of Biomarkers in Plasma and Faeces to Evaluate Physiological Status of Atlantic Salmon ( Salmo salar L.) During Salmonid Alphavirus Infection
Journal of Fish Diseases · 2025
DOI: 10.1111/jfd.14114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Fish Diseases, 2025. Verfasst von Eirik Hoel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Skretting AS, Stavanger, Norway. Hauptthemen laut MEDLINE: Fish Diseases, Salmo salar, Alphavirus, Alphavirus Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Norges Forskningsråd.
Abstract (Originalsprache)
Salmonid alphavirus (SAV) is the causative agent of pancreas disease (PD), a disease that can cause severe implications for marine farming of Atlantic salmon. This study examines physiological changes in Atlantic salmon during SAV infection through a controlled trial and two field trials. In the controlled trial, plasma creatine kinase (CK), alanine aminotransferase (ALAT) and aspartate aminotransferase (ASAT) levels increased significantly 4 weeks post challenge, peaked at 8 weeks and by 12 weeks, ALAT levels returned to pre‐challenge levels, while CK and ASAT remained elevated. Weekly mortality peaked at 4.1% in week 5, and there was an 89% reduction in appetite in week 4 post challenge. In two field trials in southern Norway, SAV3 was detected in spring/early summer by reverse transcription quantitative polymerase chain reaction (RT‐qPCR). As SAV prevalence increased, plasma CK, ALAT, ASAT and lactate dehydrogenase (LDH) levels peaked, along with the stress markers cortisol and tetrahydrocortisone in faeces. Despite low mortality (< 0.2% weekly), a decrease in appetite was observed in both field trials. Understanding the physiological status of the fish through monitoring tools like RT‐qPCR, blood chemistry and stress markers provides a foundation for implementing mitigation measures such as stress reduction, timed harvest or clinical nutrition at the onset of pancreas disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Skretting AS, Stavanger, Norway.
- Skretting Aquaculture Innovation AS, Stavanger, Norway.
- FishLab AS, Stavanger, Norway.
- VESO Vikan, Namsos, Norway.
- Åkerblå AS, Haugesund, Norway.
- Grieg Seafood ASA, Bergen, Norway.
ORCID-Profile: Eirik Hoel, Frederike Keitel-Gröner
Förderung
- Norges Forskningsråd
Zitieren
APA
Hoel, E., Keitel-Gröner, F., Husebø, C. A., Knudsen, D. L., Mullins, J., Wallace, C., Persson, H. L., Bjerke-Ertenstein, H. S., Bjerkeset, M. I., & Berge, K. (2025). Use of Biomarkers in Plasma and Faeces to Evaluate Physiological Status of Atlantic Salmon ( Salmo salar L.) During Salmonid Alphavirus Infection. Journal of Fish Diseases. https://doi.org/10.1111/jfd.14114
Vancouver
Hoel E, Keitel-Gröner F, Husebø CA, Knudsen DL, Mullins J, Wallace C, et al. Use of Biomarkers in Plasma and Faeces to Evaluate Physiological Status of Atlantic Salmon ( Salmo salar L.) During Salmonid Alphavirus Infection. Journal of Fish Diseases. 2025. doi:10.1111/jfd.14114
BibTeX
@article{Hoel2025,
author = {Hoel, Eirik and Keitel-Gröner, Frederike and Husebø, Christina Aspaas and Knudsen, David Lausten and Mullins, Julia and Wallace, Christian and Persson, Hanne Log and Bjerke-Ertenstein, Hanna S and Bjerkeset, Maren Iden and Berge, Kjetil},
title = {Use of Biomarkers in Plasma and Faeces to Evaluate Physiological Status of Atlantic Salmon ( Salmo salar L.) During Salmonid Alphavirus Infection},
journal = {Journal of Fish Diseases},
year = {2025},
doi = {10.1111/jfd.14114}
}
EUVIMED